aTyr Pharma Inc (ATYR:NASDAQ)
$1.0 -0.02 (-1.96%)
Analysed aTyr Pharma Inc (ATYR:NASDAQ) News Sources
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Markets Insider
Elisabeth Gardiner, PhD
PharmTech
Global PE firms line up for IndiaRF’s Synthimed Labs in $150-200 million deal
Mint
Zydus launches biosimilar for ophthalmic care
India Brand Equity Foundation
Novartis AG to exit listed India unit in $159 mn deal with ChrysCapital
Business Standard
Aarey Drugs & Pharmaceuticals Share Price
The Times of India
Why is Novartis selling its listed India commercial arm?
Business Today on MSN
Swiss Drug Major Novartis AG To Sell 70% Stake In India Arm To ChrysCapital
NDTV Profit on MSN
ChrysCapital inks $159 mn control deal for Novartis India, makes open offer
VCCircle
Novartis India shares zoom on Swiss parent’s ₹1,446 cr. exit plan
The Hindu
What is the current price of aTyr Pharma Inc (ATYR:NASDAQ)?
The current price of aTyr Pharma Inc (ATYR:NASDAQ) is $1.0.
aTyr Pharma Inc (ATYR:NASDAQ) absolute price change since previous trading day?
The absolute price change of aTyr Pharma Inc (ATYR:NASDAQ) since the previous trading day is $-0.02.
aTyr Pharma Inc (ATYR:NASDAQ) percentage price change since previous trading day?
The percentage price change of aTyr Pharma Inc (ATYR:NASDAQ) since the previous trading day is -1.96%.
What is This Week's average sentiment score for aTyr Pharma Inc (ATYR:NASDAQ)?
This Week's average sentiment score for aTyr Pharma Inc (ATYR:NASDAQ) is 76 out of 100.
What is This Week's average sentiment for aTyr Pharma Inc (ATYR:NASDAQ)?
This Week's sentiment for aTyr Pharma Inc (ATYR:NASDAQ) is .
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.